ONE BIO CORP. | Sales 2009 | 22.07M 1.84B | Sales 2010 | 52.3M 4.36B | Capitalization | 39.97M 3.33B |
|---|---|---|---|---|---|
| Net income 2009 | 4M 334M | Net income 2010 | 8M 667M | EV / Sales 2009 | 8.69 x |
| Net Debt 2009 | 12.16M 1.01B | Net Debt 2010 | 9.04M 754M | EV / Sales 2010 | 0.94 x |
| P/E ratio 2009 |
43.1
x | P/E ratio 2010 |
4.81
x | Employees | - |
| Yield 2009 * |
-
| Yield 2010 |
-
| Free-Float | 93.6% |
More Fundamentals
* Assessed data
| Managers | Title | Age | Since |
|---|---|---|---|
Cris M. Neely
DFI | Director of Finance/CFO | 66 | 11/09/11 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Frank Klees
BRD | Director/Board Member | 72 | 12/10/12 |
James Fernandes
BRD | Director/Board Member | 53 | 12/10/12 |
Cris M. Neely
DFI | Director of Finance/CFO | 66 | 11/09/11 |
ONE Bio, Corp. (ONE), formerly ONE Holdings, Corp. is a bio-engineering company that utilizes green process manufacturing to produce raw chemicals and herbal extracts, natural supplements and organic products. Its key products include Solanesol, CoQ10, Resveratrol and 5-HTP, organic fertilizers, and organic bamboo health food and beverages. Its operations are divided into two principal complementary business units that focus on producing chemical and herbal extracts (CHE business unit) and organic products utilizing green processes (OP business unit).
Sector
Food Processing
| 1st Jan change | Capi. | |
|---|---|---|
| +8.20% | 7.78B | |
| +1.64% | 7.38B | |
| +10.20% | 6.52B | |
| -8.10% | 3.67B | |
| -14.57% | 1.17B | |
| +8.34% | 934M | |
| -42.27% | 879M | |
| -18.90% | 836M | |
| -16.45% | 802M |
